The primary aim of the brain imaging research group is to develop and use imaging techniques to diagnose and guide treatment of psychiatric diseases. For several years the multidisciplinary team has focused primarily on MRI.
Recently, investigators have expanded to the field of functional and multinuclear imaging of phosphorus and lithium, as well as PET imaging both in preclinical models and human subjects. Advancements in this field are bringing novel insights into complex mental illnesses.
- Paul E. Croarkin, D.O.
- Heidi A. Edmonson, Ph.D.
- Joel P. Felmlee, Ph.D.
- Mark A. Frye, M.D.
- John D. Port, M.D., Ph.D.
- Susannah J. Tye, Ph.D.
- Marin Veldic, M.D.
- Christopher A. Wall, M.D.
- Stephen P. Whiteside, Ph.D., L.P.
|Investigator & Role
|Mark A. Frye, M.D., principal investigator
||1H-MR Spectroscopy of Bipolar Depression Before and After Lamotrigine Treatment
||National Institute of Mental Health